Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 12, pp. 1566-1581
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 14, 2018
- Revision received July 14, 2018
- Accepted August 28, 2018
- Published first September 5, 2018.
Article Versions
- Previous version (September 5, 2018 - 06:51).
- Previous version (November 15, 2018 - 06:07).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Haley E. Ramsey1,
- Melissa A. Fischer1,
- Taekyu Lee2,3,
- Agnieszka E. Gorska1,
- Maria Pia Arrate1,
- Londa Fuller1,
- Kelli L. Boyd4,
- Stephen A. Strickland1,5,
- John Sensintaffar2,
- Leah J. Hogdal2,
- Gregory D. Ayers5,6,7,
- Edward T. Olejniczak2,3,
- Stephen W. Fesik2,3,5 and
- Michael R. Savona1,5,*
- 1Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
- 2Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee.
- 3Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, Tennessee.
- 4Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
- 5Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
- 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee.
- 7Vanderbilt Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee.
- ↵*Corresponding Author:
Michael R. Savona, Vanderbilt University School of Medicine, 777 Preston Research Building, 2200 Pierce Avenue, Nashville, TN 37232. Phone: 615-936-3321; Fax: 615-343-7602; E-mail: michael.savona{at}vanderbilt.edu
December 2018
Volume 8, Issue 12
Volume 8, Issue 12
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
Jump to section
Advertisement